Brenntag signed an exclusive global distribution agreement to commercialize Insempra's Omega‑7 biolipid, marketed as CosVivet ActiLipid O7, the first product under a broader strategic collaboration. Technical and manufacturing CosVivet ActiLipid ...
Brenntag signed an exclusive global distribution agreement to commercialize Insempra's Omega‑7 biolipid, marketed as CosVivet ActiLipid O7, the first product under a broader strategic collaboration. Technical and manufacturing CosVivet ActiLipid ...
Tags: All Chemicals,Central and East Europe,English,Europe,Germany,News
Published on April 9, 2026 12:17 PM (GMT+8)SHARE THIS STORY
